Mono Pharmacare Ltd
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
- Market Cap ₹ 18.6 Cr.
- Current Price ₹ 10.5
- High / Low ₹ 27.5 / 9.45
- Stock P/E 53.0
- Book Value ₹ 17.9
- Dividend Yield 0.00 %
- ROCE 4.51 %
- ROE 1.12 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.59 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 7.18% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 165 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 6m | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 33 | 122 | 168 | 166 | |
| 31 | 116 | 161 | 162 | |
| Operating Profit | 2 | 6 | 8 | 4 |
| OPM % | 7% | 5% | 5% | 2% |
| 0 | 0 | 1 | 0 | |
| Interest | 1 | 3 | 4 | 3 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 3 | 4 | 1 |
| Tax % | 29% | 24% | 30% | 40% |
| 1 | 2 | 3 | 0 | |
| EPS in Rs | 0.76 | 1.38 | 1.75 | 0.20 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 71% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -28% |
| TTM: | -89% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 12 | 18 | 18 | 18 |
| Reserves | 1 | 10 | 14 | 14 |
| 40 | 41 | 54 | 56 | |
| 9 | 12 | 25 | 34 | |
| Total Liabilities | 63 | 81 | 110 | 122 |
| 1 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 |
| 61 | 80 | 109 | 121 | |
| Total Assets | 63 | 81 | 110 | 122 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| -40 | -9 | -4 | ||
| -1 | 0 | -0 | ||
| 41 | 8 | 5 | ||
| Net Cash Flow | 0 | -0 | 0 | |
| Free Cash Flow | -40 | -9 | -5 | |
| CFO/OP | -1,765% | -126% | -38% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 241 | 94 | 91 | 165 |
| Inventory Days | 408 | 139 | 133 | 99 |
| Days Payable | 87 | 32 | 45 | 68 |
| Cash Conversion Cycle | 563 | 202 | 179 | 196 |
| Working Capital Days | 299 | 131 | 120 | 126 |
| ROCE % | 10% | 11% | 5% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Domestic revenue share (consolidated) % |
|
||
| Number of associates and joint ventures count ・Standalone data |
|||
| Number of permanent employees employees ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
General Updates
16 July 2026 - Surana and Kothari Associates LLP consents to act as Secretarial Auditor and Scrutinizer for FY 2026-27.
-
Change in Auditors
16 July 2026 - BG Kalal & Co. consented to act as Internal Auditor for FY 2026-27.
-
Resignation of Director/KMP/SMP
16 July 2026 - Mono Pharmacare Limited has informed about Resignation of Director/KMP/SMP
-
Outcome of Board Meeting
16 July 2026 - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026.
-
Resignation
16 July 2026 - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026.
Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.